GNPTAB Gene Mucolipidosis Type 3 Genetic Test sale cost 4400 AED
MT-TL1 Gene MELAS Syndrome MT-TL1 Related Genetic Test sale cost 4400 AED MT-TL1 Gene MELAS Syndrome MT-TL1 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
AMPD1 Gene Myopathy Due to Myoadenylate Deaminase Deficiency Genetic Test sale cost 4400 AED AMPD1 Gene Myopathy Due to Myoadenylate Deaminase Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GNPTAB Gene Mucolipidosis Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GNPTAB gene mucolipidosis type 3 genetic test is a specialized diagnostic tool designed to identify mutations in the GNPTAB gene, which are responsible for mucolipidosis type 3 (ML III), also known as pseudo-Hurler polydystrophy. Mucolipidosis type 3 is a rare lysosomal storage disorder characterized by the body’s inability to properly break down certain fats and carbohydrates, leading to a range of symptoms including skeletal abnormalities, joint stiffness, and heart valve problems. This genetic test is crucial for early diagnosis and management of the condition, allowing for better clinical outcomes and informed genetic counseling for affected families.

Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test offers a reliable analysis of the GNPTAB gene. The cost for this comprehensive genetic test is 4400 AED. By choosing DNA Labs UAE, patients can expect accurate results, professional service, and the assurance that comes from working with a leading laboratory in the field of genetic diagnostics.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GNPTAB Gene Mucolipidosis type 3 Genetic Test

At DNA Labs UAE, we offer the GNPTAB Gene Mucolipidosis type 3 Genetic Test. This test is designed to detect mutations or variations in the GNPTAB gene, which is associated with a rare genetic disorder called mucolipidosis type 3 (MLIII).

Test Details

MLIII is an autosomal recessive lysosomal storage disorder characterized by the accumulation of mucopolysaccharides and sphingolipids in various tissues and organs of the body. Our NGS (Next-Generation Sequencing) technology allows for the sequencing of multiple genes simultaneously, including the GNPTAB gene.

Components

  • Test Name: GNPTAB Gene Mucolipidosis type 3 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the GNPTAB Gene Mucolipidosis type 3 NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with Mucolipidosis type 3.

Test Process

The NGS genetic test for MLIII involves collecting a sample of DNA, usually through a blood sample or cheek swab. The collected sample will then undergo advanced sequencing technologies to sequence the GNPTAB gene. The results of the test will confirm a diagnosis of MLIII and provide information about the specific genetic variants present in the GNPTAB gene.

Who Should Take the Test?

This type of genetic testing can be useful for individuals who have symptoms suggestive of MLIII or have a family history of the condition. It can also be used for carrier testing in individuals with a family history of MLIII to determine if they carry a mutation in the GNPTAB gene.

It’s important to note that genetic testing for MLIII should be done under the guidance of a healthcare professional or genetic counselor who can help interpret the results and provide appropriate counseling and support.

Test Name GNPTAB Gene Mucolipidosis type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GNPTAB Gene Mucolipidosis type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Mucolipidosis type 3
Test Details

The GNPTAB gene is associated with a rare genetic disorder called mucolipidosis type 3 (MLIII). MLIII is an autosomal recessive lysosomal storage disorder characterized by the accumulation of certain substances (mucopolysaccharides and sphingolipids) in various tissues and organs of the body.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the sequencing of multiple genes simultaneously. It is used to identify mutations or variations in the GNPTAB gene that may be responsible for causing MLIII.

The NGS genetic test for MLIII involves collecting a sample of DNA, usually through a blood sample or cheek swab, and then sequencing the GNPTAB gene using advanced sequencing technologies. The results of the test can help confirm a diagnosis of MLIII and provide information about the specific genetic variants present in the GNPTAB gene.

This type of genetic testing can be useful for individuals who have symptoms suggestive of MLIII or have a family history of the condition. It can also be used for carrier testing in individuals with a family history of MLIII to determine if they carry a mutation in the GNPTAB gene.

It’s important to note that genetic testing for MLIII should be done under the guidance of a healthcare professional or genetic counselor who can help interpret the results and provide appropriate counseling and support.

SKU: TEST-2558 Category:

Related products